ArticleThe Journal of antimicrobial chemotherapy2023

Development of an in vitro pharmacokinetic/pharmacodynamic model in the presence of serum for studying micafungin activity against Candida albicans: a need for revision of CLSI susceptibility breakpoints.

Maria-Ioanna Beredaki et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.